Skip to content

Clinical trials

Phase 1/2 Head and Neck Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Phase 1/2 Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20151
20172
20191
20202
20211
20221
20231
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Terminated4
Active, not recruiting2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Aminex Therapeutics, Inc.1
Dynavax Technologies Corporation1
Full-Life Technologies UK Limited1
Lumara Bio Oncologics GmbH1
Onchilles Pharma Inc1
PMV Pharmaceuticals, Inc1
Second Life Therapeutics1
Shasqi, Inc.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms13
Carcinoma, Non-Small-Cell Lung9
Lung Neoplasms7
Colorectal Neoplasms6
Neoplasms6
Breast Neoplasms5
Colonic Neoplasms4
Melanoma4
Neoplasm Metastasis4
Ovarian Neoplasms4

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.